Welcome to Cabometyx.eu website. This website is intended for EU Healthcare professionals only.
Please confirm below that you are a registered healthcare professional.
I AM A EU HEALTHCARE PROFESSIONAL
This site is intended to provide healthcare professionals with information on CABOMETYX® and its therapeutic use in renal cell carcinoma (RCC).
Indications, mechanism of action, dosing and administration and adverse event information.
Information on CABOMETYX® clinical trials in RCC, including the CABOSUN study and METEOR study.
Current European clinical practice guidelines for the management of RCC.
I AM A EU HEALTHCARE PROFESSIONAL